Last updated on May 2020

A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

Brief description of study

The reason for this study is to see if the study drug mirikizumab is safe and effective in participants with moderately to severely active Crohn's disease.

Clinical Study Identifier: NCT03926130

Find a site near you

Start Over

Latin Clinical Trial Center

San Juan, Puerto Rico
  Connect »